URB602
Names | |
---|---|
IUPAC name
Cyclohexyl [1,1'-biphenyl]-3-ylcarbamate
|
|
Other names
[1,1'-Biphenyl]-3-yl-carbamic acid, cyclohexyl ester
|
|
Identifiers | |
565460-15-3 | |
ChEMBL | ChEMBL77767 |
ChemSpider | 9154538 |
Jmol 3D model | Interactive image |
PubChem | 10979337 |
|
|
|
|
Properties | |
C19H21NO2 | |
Molar mass | 295.38 g·mol−1 |
Appearance | Crystalline solid |
Vapor pressure | {{{value}}} |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
verify (what is ?) | |
Infobox references | |
URB602 ([1,1'-biphenyl]-3-yl-carbamic acid, cyclohexyl ester) is a compound that has been found to inhibit hydrolysis of monoacyl glycerol compounds, such as 2-arachidonoylglycerol (2-AG) and 2-oleoylglycerol (2-OG). It was first described in 2003.[1] A study performed in 2005 found that the compound had specificity for metabolizing 2-AG over anandamide (another cannabinoid ligand) in rat brain presumably by inhibiting the enzyme monoacylglycerol lipase (MAGL), which is the primary metabolic enzyme of 2-AG.[2] However, subsequent studies have shown that URB602 lacks specificity for MAGL inhibition in vitro.[3]
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
<templatestyles src="Asbox/styles.css"></templatestyles>